Can Hims stand up to legal scrutiny?

The weight loss drug shortage is driving patients to Hims. What happens when the shortage ends?

August 29, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | The weight loss drug shortage is driving patients to Hims. What happens when the shortage ends? Selling copies of weight loss drugs such as Wegovy and Ozempic is only allowed during shortages. Can Hims & Hers find ways to avoid FDA action? By Katie Palmer and Nicholas Florko STAT+ | Thoughts, takes, and burning biotech questions as the beginning of the end of the year approaches Today's biotech news roundup includes ruminations on Alnylam Pharmaceuticals, BridgeBio Pharma, and Summit Therapeutics. By Adam Feuerstein Opinion: Conversations about improving prenatal care must include transgender and gender diverse birthing people Many trans and gender diverse people have given birth or want to — and they should be part of prenatal care conversations. By Gavin Fraser Adobe Switching asthma inhalers could reduce carbon emissions, says study Stanford researcher says hydrofluorocarbons used in inhalers for asthma and COPD have the same greenhouse gas impact as powering a medium-sized city. By Brittany Trang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser